Systematic Review
Copyright ©The Author(s) 2019.
World J Meta-Anal. Jun 30, 2019; 7(6): 269-289
Published online Jun 30, 2019. doi: 10.13105/wjma.v7.i6.269
Table 3 Morbidity, mortality and survival rates after multivisceral resection for colon and rectal cancer
StudyFollow-up (mo)Morbidity (%)Mortality (%)Survival1Stage IV disease (%)True pT4b (%)
Cukier et al[24]363603-yr OS: 85.9%; 3-yr DFS: 73.7%067
Hallet et al[20]5433.3090%; 5-yr DFS: 63.5%050
Kumamoto et al[15]3217.80.887%1245
Leijssen et al[2]48.52505-yr OS (pT3): 63%; 5-yr OS (pT4): 70%024
López-Cano et al[49]74.947.87.148%; 5-yr DFS: 46.3 mo2065
Rosander et al[7]2837% (≥ Grade III)560.8% for the infiltration group; 86.9% for the inflammation group063
Takahashi et al[12]48.4LAP: 7 OPEN: 3603-ys OS (open): 79.8%; (lap): 92.8%2550
Tei et al[23]3437.903-yr OS Stage II-III (S-MVR/M-MVR): 81.8%/80.0% 3-yr DFS Stage II-III (S-MVR/M-MVR: 58.3%/70.0%2834
Chen et al[6]NR11.5NR59% (Colon/inflammation) 39% (Colon/invasion) 63% (Rectum/inflammation); 42% (Rectum/invasion)5455
Eveno et al[58]48121.377%; 3-yr OS (without stage IV disease): 89%; 5-yr DFS: 58%1365
Fujisawa et al[29]42 (mean)NRNR3-yr OS (colon/bladder sparing): 90%; (colon/nonsparing): 67%; 3 yr OS (rectal/bladder sparing): 50%; (rectal/nonsparing): 67%NRNR
Hoffmann et al[21]NR34.67.755% (if curative)4963
Gezen et al[18]25 (mean)24.44.469.4%1234
Kim et al[17]35/40 (mean)LAP: 21 OPEN: 440LAP: 60.5%; OPEN 48%3344
Laurence et al[56]NRNRNR52.7%3NR
Lehnert et al[8]71337.551%550
Li et al[16]64.3615.650%; 59%: if curative2147
Park et al[53]NR35.23.158%044
Rizzuto et al[57]NR5503-yr OS (non-occlusive): 58.4%; (occlusive): 33.3%077
Winter et al[1]84181.557%; 61% (R0); 17% (R1) 77% (R0, N0); 28% (R0, N+)NR54
Banmura et al[56]32500Local recurrence rate: 30%3363
Crawshaw et al[25]27.857.4049.2%; 5-yr DFS: 45.3%039
Derici et al[48]40.4 (mean)38.63.549%; 3-yr OS: 81.6%058
Dinaux et al[50]38.272.40OS: 45 mo024
Dosokey et al[30]32 (mean)39067%; 5-yr DFS: 79%0NR
Gannon et al[28]4043048%; Primary: 65% Recurrent: 22%; 5-yr DFS. 38%; Primary: 52% Recurrent: 13%NRNR
Harris et al[19]305005-yr OS (R0): 48%; R1/R2: 33%1452
Ishiguro et al[54]4039.82.252%; 5-yr DFS: 46%NR49
Mañas et al[13]28.876.61036.7%2067
Nielsen et al[9]12512.25-yr OS (primary): 46%; (recurrent):17%0NR
Pellino et al[14]NR54.92.467%NR70
Rottoli et al[10]32.5/56.633 Primary: 32% Recurrent: 33%45-yr DFS (primary): 46% (recurrent): 24%NRNR
Sanfilippo et al[51]NR25NR4-yr OS: 69%044
Shin et al[22]3041.7080%2723
Smith et al[47]NR47.60.853.3%; M0: 59%2044
Vermaas et al[11]28 (mean)69; Primary: 61; Recurrent: 83352% (primary); 3-yr OS (recurrent): 32%NR43